Technologies for sampling abnormal cells in the oesophagus

Preliminary market consultation to inform the NHS commercial strategy for Technologies that sample abnormal cells in the oesophagus. Please note all stated financial values in relation to this notice are nominal, as the financial envelope is yet to be defined. Projected contracting dates in the notice, similarly do not reflect any plans as these are yet to be defined. To express interest, review and respond to the request for information questionnaire please register and apply via Atamis e-sourcing portal using the...